Introduction: We report a case of a young female patient, previously affected by psoriatic
arthritis, and treated with adalimumab, who developed a chronic spontaneous urticaria and …

Targeting plasma IgE by therapeutic mABs like Omalizumab (Xolair®) is current clinical
practice for severe allergic conditions or other IgE related diseases like chronic urticaria. As …

Immunoglobulin E (IgE) plays a central role in the pathogenesis of Type I hypersensitivity
through interaction with a high-affinity receptor (FcεRIα). For therapeutic applications …

Atopic dermatitis (AD) is a prevalent protracted inflammatory skin condition that affects
approximately 12% of children globally. Topical remedies, such as pharmacologic and …

Objective To analyze whether the ratio of total IgE level at week 16 to baseline could be
used as an indicator to evaluate clinical efficacy of patients treated with omalizumab …

Sažetak Astma u dječjoj dobi jest heterogena kronična upalna bolest donjih dišnih puteva
koja se očituje od rane životne dobi različitim fenotipovima i endotipovima, koji se mogu …

Allergic rhinitis (AR) is a chronic inflammatory reaction by immunoglobulin E (IgE) mediators
after individual contact with allergens. It affects 10–40% of the world's population and …

Introduction: Autoimmune blistering skin diseases are a group of disorders subdivided
according to the location of blister formation: intraepidermal blistering in the pemphigus …

Background: DB-1003 is a humanized anti-IgE monoclonal antibody with higher affinity than
omalizumab. In the affinity capture elution (ACE)-based bridging electrochemiluminescent …

В статье описан современный подход к применению антиIgE-терапии при
аллергической бронхиальной астме и сопутствующих этому заболеванию состояниях …